Galectin-10

BE0001886ProteinHumansCLC

Regulates immune responses through the recognition of cell-surface glycans. It is acted on by 2 drugs in DrugBank.

Gene name
CLC
UniProtKB entry
Q05315Swiss-Prot
Cellular location
Cytoplasm, cytosol
Residues / weight
142 residues · 16,453 Da
Also known as
Charcot-Leyden crystal protein · CLC · Eosinophil lysophospholipase · Gal-10 · LGALS10

Resolves to

Protein
UniProtQ05315UniProt nameLEG10_HUMAN
Gene
HGNCHGNC:2014NCBI Gene1178GenBank187274GeneCardsCLC
Pharmacology
KEGGhsa:1178
Structure
PDB1G86PDB1HDKPDB1LCL
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
18+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Galectin-10, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In